Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study
J Eur Acad Dermatol Venereol
.
2024 Sep 13.
doi: 10.1111/jdv.20341.
Online ahead of print.
Authors
Annunziata Raimondo
1
,
Paolo Amerio
2
,
Anna Balato
3
,
Francesco Cusano
4
,
Maria Concetta Fargnoli
5
,
Claudio Guarneri
6
,
Luigi Ligrone
7
,
Matteo Megna
8
,
Maria Letizia Musumeci
9
,
Rosa Valentina Puca
10
,
Maria Teresa Uzzauto
11
,
Serena Lembo
1
Affiliations
1
Department of Medicine Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
2
Dermatology Unit, University of G. D'Annunzio, Chieti, Italy.
3
Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
4
Dermatology Unit, "G. Rummo" Hospital, Benevento, Italy.
5
Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
6
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology, University of Messina, Messina, Italy.
7
Dermatology Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy.
8
Section of Dermatology, Department of Clinical, Medicine and Surgery, University of Naples Federico II, Naples, Italy.
9
Department of Dermatology, University of Catania, Catania, Italy.
10
Dermatology and Dermosurgery, "San Giuseppe Moscati" National Hospital (AORN), Contrada Amoretta, Avellino, Italy.
11
Dermatology Unit, A. Tortora Hospital, Pagani, Salerno, Italy.
PMID:
39269027
DOI:
10.1111/jdv.20341
No abstract available
Publication types
Letter